What "research grade" actually means on a peptide label

"Research grade" appears on almost every peptide sold in this category, and it is used to mean at least three different things: a legal scope, a purity level, and, occasionally, a wink. Only the first is correct. This note sets out what the term commits a supplier to, what it does not, and what to ask for if you want to know whether it is backed by anything.

It is a statement of scope, not of quality

The phrase describes what the material is for: laboratory investigation, in vitro, by people equipped to handle it. It does not describe how good it is. A 99.8 per cent research-grade peptide and a 96 per cent research-grade peptide are both research grade. The term draws a boundary around intended use; purity is a separate axis entirely, and it is the one that needs a number attached.

This matters practically because the two get conflated in marketing copy. "Research grade" is sometimes deployed as though it were a tier above ordinary and below pharmaceutical. It is not a tier. It is a scope.

What it is not

It is not pharmaceutical grade. Pharmaceutical grade describes material manufactured under a regulated quality system and released against a pharmacopoeial or authorised specification for use in a medicinal product.¹ Research-grade material is released against a supplier's own analytical specification, without marketing authorisation. A high purity figure does not convert one into the other, and no supplier in this category should imply that it does.

It is not a claim about safety. Nothing in the phrase says anything about toxicology, sterility, endotoxin, or suitability for any organism. Where those attributes matter for a given experiment, they have to be tested for specifically and stated separately.

It is not a workaround. The designation constrains what the material may be supplied for. Supplying on a research basis while marketing on any other basis is precisely the behaviour that draws regulatory attention, and it is the reason this site carries no effect claims, no testimonials describing outcomes, and no imagery implying personal use.

What a specification actually contains

A specification is a list of tests, each with a method and an acceptance criterion.^1,2 For a synthetic research peptide the useful minimum is:

• Identity. Expected mass against observed mass, by ESI-MS.
• Purity. A criterion such as not less than 99.0 per cent main-peak area, by RP-HPLC on a stated column at a stated wavelength.^3,4
• Appearance. What an acceptable cake looks like.
• Water content. Usually by Karl Fischer, because it is the largest unstated mass term in a lyophilised vial.
• Storage and retest date. The conditions under which the above remains true.

Notice that every line has a method attached. "High purity" is not a specification. "NLT 99.0 per cent main-peak area by RP-HPLC, C18, 214 nm" is a specification, because it can be failed.

Specification versus batch record

These are two different documents and both are needed. The specification is what every batch must meet. The batch record, or Certificate of Analysis, is what one specific batch actually measured, on what date, at which named laboratory.^5,6 A supplier that publishes a specification but no batch records is telling you their intent. A supplier that publishes batch records but no specification is telling you a result with no context. You want both, and you want them before the transaction rather than after it.

Our position

Isoform publishes the specification on every catalogue entry and the batch record against every released batch number, retrievable in one field with no account. Our purity criterion is not less than 99.0 per cent main-peak area by RP-HPLC on C18 at 214 nm, with identity confirmed by ESI-MS against the calculated mass. Batches that miss either criterion are rejected, not repriced, and never enter the catalogue. Mean released purity across 2025–26 was 99.4 per cent. A worked example is batch IF-26-4471.